A Study to Evaluate the Drug-drug Interactions (DDIs) of GP681 With Rosuvastatin, Digoxin, Itraconazole, Oseltamivir in Chinese Healthy Volunteers

NCT05789342 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: GP681
DRUG: Rosuvastatin
DRUG: Digoxin
DRUG: Itraconazole
DRUG: Oseltamivir

Sponsor

Jiangxi Qingfeng Pharmaceutical Co. Ltd.